about
Profile of omalizumab in the treatment of chronic spontaneous urticariaUsefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysisManagement of urticaria: not too complicated, not too simpleAllergic diseases in the elderlyFamilial CD8 deficiency due to a mutation in the CD8 alpha gene.Guidelines on the clinical usefulness of determination of specific immunoglobulin E to foods.Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis.In vitro diagnosis of immediate allergic reactions to drugs: an update.Malignancy and myositis: novel autoantibodies and new insights.Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable?Assessment of severity and quality of life in chronic urticaria.Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools.Immunotherapy in allergic rhinitis and lower airway outcomes.Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements.[Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update].The Mast Cell, Contact, and Coagulation System Connection in AnaphylaxisInduction of cell death by sera from patients with acute brain injury as a mechanism of production of autoantibodies.Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.Identification of thaumatin-like protein and aspartyl protease as new major allergens in lettuce (Lactuca sativa).Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients.Identification of a novel myositis-associated antibody directed against cortactin.Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.Relevance of Allergenic Sensitization to Cynodon dactylon and Phragmites communis: Cross-reactivity With Pooideae Grasses.A newborn with erythematous, desquamative plaques.Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy.Anaphylaxis Induced by Conlinin, a 2S Storage Protein in Flaxseed.Vertebrate Tropomyosin as an Allergen.Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.Severe anaphylaxis due to crocodile-meat allergy exhibiting wide cross-reactivity with fish allergens.Mixed Connective Tissue Disease and Epitope Spreading: An Historical Cohort Study.Component-Resolved Diagnosis of Dog Allergy.[Common variable immunodeficiency. Prognostic factors for lung damage].Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.Anti-MDA5 dermatomyositis and progressive interstitial pneumonia.Omalizumab: what benefits should we expect?More on remission of recalcitrant dermatomyositis treated with ruxolitinib.Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy.Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele.
P50
Q26783158-AC8721E7-5E56-4885-8B5E-9CD22DC91686Q26825582-749CB04E-AB8C-4F90-9AE6-CFB23FA473A5Q26828373-6E0B56FB-B106-4E6F-A1B4-F905FA0F250CQ35919934-8212BEE1-7501-4E7B-80CA-89C8C8D7708FQ36167336-CB1DA851-416C-4361-AA1A-76721932C2E7Q37686492-4C660501-428C-4F04-9FF8-7480A5162F65Q37704772-864F5151-6966-4405-8737-1A1CD76AD84BQ37749734-C1981783-C2A8-491B-B8C2-AF7A5F117A06Q37786518-A9A4F45C-4E0F-4438-94DD-6CD853E6A736Q38198050-8B0B5578-D8C4-4C6A-8AA3-C53C4F5053A6Q38212274-7CB0354E-F040-4795-B916-1127EB03B488Q38450473-63E3AFE2-6F9D-48D0-9FE3-F938BC3C5D23Q38903486-E694503A-28A1-47C9-BAB4-ED0762D38B00Q38957797-AB965428-13BA-44F6-9048-7AC853284DE7Q39059966-E73A2863-D0DA-434D-935E-0970DD1624FCQ40332917-90360576-4674-469A-AAF9-224D3CB24CBEQ41123171-C8AE6E70-6580-4184-94C5-E83948297BF8Q44250397-2CEC36A6-D8F4-4559-B947-9A15E4E783AFQ44428095-C62C9BE8-C0E3-49EF-AE6C-F1DCAF2FA41DQ44803171-7848B927-F941-4897-8A2F-1623EC989D3EQ44925500-C7B5EA15-9D7D-4DB1-AAA6-316D1C0DFE40Q45394100-79190109-2748-4279-92C5-9B7FA84D9821Q45739841-D8D8AED4-94DD-41E2-AABC-7E8B6F7B36C4Q46474818-430075E4-6CF1-4823-80F6-1BCBA5719260Q46730685-FFFA39BB-0B3A-4BFC-A528-2B55F6E5A297Q47737473-21F43463-C7E2-44F9-9EC8-48498193124EQ47961123-21715933-7DC4-4F1A-ADF9-520FD6BD40B4Q49815527-6BA3837C-35F4-4D13-88E3-E19C34077E1BQ49815539-8DC311BF-865E-4C0B-882B-58E3CCE360E8Q49921821-6E778C71-F32C-4556-900E-0DBA43E50551Q50038669-C8E52DEA-1BA3-4E81-9EBA-1B7B9837B0F1Q50867176-24A76BCB-BE69-4E17-A14A-C0B52C78999CQ50965839-7A3D417B-B578-41FD-AB4F-343A99BC2436Q51889871-ED9E1DD0-C3F2-4DC3-8FCE-13FACF74BCD4Q52688656-0B73E918-7231-405A-8E17-5C2A6D55A8E4Q53579180-6E85AF05-4E33-44A7-92AD-3E7561E51A43Q53606388-8FE742A9-818E-45D5-9330-EF437EA12607Q54282407-76D3803F-36D9-49DE-B09F-4AA7D4B45E12Q54446318-58D121EC-1ECC-4F81-B221-A50D37014105Q54572337-F8CC2BFD-3A72-4F37-81F5-C99F2E678D5E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Moises Labrador-Horrillo
@ast
Moises Labrador-Horrillo
@en
Moises Labrador-Horrillo
@es
Moises Labrador-Horrillo
@nl
Moises Labrador-Horrillo
@sl
type
label
Moises Labrador-Horrillo
@ast
Moises Labrador-Horrillo
@en
Moises Labrador-Horrillo
@es
Moises Labrador-Horrillo
@nl
Moises Labrador-Horrillo
@sl
prefLabel
Moises Labrador-Horrillo
@ast
Moises Labrador-Horrillo
@en
Moises Labrador-Horrillo
@es
Moises Labrador-Horrillo
@nl
Moises Labrador-Horrillo
@sl
P106
P31
P496
0000-0003-3222-2380